h.jansen
TL2 · Ibadan
Contributes reviews on supplier material. Based in Ibadan.
Joined 11 December 2024 · last posted 9d
79 posts, newest first. Showing up to 150.
-
Why the Start Here categories exist, and what they are not for Replied, post #11 · Start Here › Welcome · 18 Jul 2026 · 3 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
-
Substitution between formats during a shortage — what changed since Replied, post #15 · Access › Shortages · 15 Jul 2026 · 0 likes Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite. I would be glad to be shown a cleaner way of…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #44 · Practice › Dosing & titration · 7 Jul 2026 · 19 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Journal club: what we got wrong in an earlier session Replied, post #58 · Evidence › Journal club · 6 Jul 2026 · 25 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #12 · Start Here › Welcome · 5 Jul 2026 · 23 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #7 · Clinical › Bloodwork · 24 Jun 2026 · 6 likes Post #4 is the version of this I will quote in future. One addition. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
-
Alcohol: what is documented and what is folklore Replied, post #69 · Practice › Interactions · 21 Jun 2026 · 3 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #61 · Wellbeing › Sleep · 17 Jun 2026 · 9 likes Confirming post #60 from a second method, which matters more than confirming it from a second person. Marking my uncertainty on Sleep apnoea explicitly. I am confident…
-
Reading a home test result without over-claiming Replied, post #69 · Analytics › Home & field testing · 6 Jun 2026 · 0 likes Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
-
The most useful thing you learned here that was not the answer you came for Replied, post #48 · Lounge › Off topic · 6 Jun 2026 · 4 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors. Someone will know this better than I do and I hope they say so.
-
Revisiting: The best-written scientific paper you have read Replied, post #9 · Lounge › Off topic · 31 May 2026 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #44 · Practice › Administration · 22 May 2026 · 3 likes Completing a dose is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #103 · Research Methods › Statistics · 13 May 2026 · 0 likes Measurement error in home scales has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
[2026 update] Waist circumference technique and its repeatability Replied, post #6 · Outcomes › Progress reports · 28 Apr 2026 · 29 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #111 · Analytics › Mass spectrometry · 24 Apr 2026 · 6 likes Confirming post #110 from a second method, which matters more than confirming it from a second person. My understanding of Charge states is a few years old and may have…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #97 · Practice › Reconstitution · 24 Apr 2026 · 3 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #40 · Sourcing › Independent verification · 19 Apr 2026 · 2 likes Post #39 and I disagree about the size of the effect, not about the direction. Where an independent figure and a declared figure differ by less than method…
-
Forced degradation studies: designing one that is informative Replied, post #36 · Analytics › Method validation · 13 Apr 2026 · 0 likes Forced degradation studies looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #9 · Evidence › Meta-analyses · 4 Apr 2026 · 0 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #83 · Lounge › Introductions · 16 Mar 2026 · 17 likes Hello. Fair warning that this place will change how you read a certificate, and that you will not be able to go back to accepting one at face value.
-
Five questions in one post gets you one answer — how to split them Replied, post #28 · Start Here › How to Ask · 10 Mar 2026 · 33 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #57 · Practice › Reconstitution · 9 Mar 2026 · 0 likes Narrowing post #56, because the general version has more than one answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 15 Feb 2026 · 0 likes Adding a data point of agreement rather than a data point.
-
Coverage in the US: a map of the usual obstacles Replied, post #51 · Regional › North America · 14 Feb 2026 · 15 likes Picking up post #48: that is the part I would want checked first. Coverage decisions are made by individual payers and vary within the same jurisdiction. A denial from…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #74 · Documentation › Wiki requests · 6 Feb 2026 · 15 likes I had written a reply contradicting post #71 and deleted it. Here is what survived. Review cadence should be part of the proposal. A page about a fast-moving area needs…
-
Cardiovascular risk: reading the outcome trials as a set Replied, post #4 · Clinical › Comorbidities · 3 Feb 2026 · 28 likes Picking up the opening post: that is the part I would want checked first. Mechanistic reasoning about a population that was excluded from the trials has an unimpressive…
-
Trifluoroacetate content and its consequences Replied, post #16 · Analytics › Impurities & related substances · 24 Jan 2026 · 0 likes Post #14 put the caveat in the right place and I want to underline it. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #3 · Practice › Interactions · 20 Jan 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
A plateau that disappeared when I changed how I measured Replied, post #9 · Outcomes › Progress reports · 18 Jan 2026 · 31 likes I would put moderate confidence on the mainstream reading of plateau and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #88 · Compounds › Semaglutide · 8 Jan 2026 · 0 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #9 · Sourcing › Logistics · 18 Dec 2025 · 0 likes Adding the measurement that post #8 says would settle it. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
Publishing an inconvenient result: a case study — the long version Replied, post #68 · Sourcing › Independent verification · 12 Dec 2025 · 0 likes Narrowing post #66, because the general version has more than one answer. A request rather than an answer: could whoever has the primary source for Publishing an…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #33 · Access › Pricing · 9 Dec 2025 · 0 likes Summarising the Price changes thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #21 · Analytics › HPLC & UHPLC · 20 Nov 2025 · 1 like I had written a reply contradicting post #20 and deleted it. Here is what survived. Change the wavelength and the proportions change even though the sample has not.…
-
Comparing two chromatograms from different laboratories, properly Replied, post #32 · Analytics › HPLC & UHPLC · 19 Nov 2025 · 26 likes Taking post #29 at face value and following it one step further. On integration: where the baseline is drawn matters more than most people realise. On a clean…
-
Pen dose counters: what a click does and does not guarantee Replied, post #13 · Devices › Pens & autoinjectors · 13 Nov 2025 · 9 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
[2026 update] What steady state means for the decision to escalate Replied, post #38 · Practice › Dosing & titration · 8 Nov 2025 · 27 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. I…
-
Titles that describe the question, not the situation Replied, post #133 · Start Here › How to Ask · 27 Oct 2025 · 14 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Moderation log format change Replied, post #5 · Meta › Announcements · 27 Oct 2025 · 13 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. I would treat the number as indicative rather than as…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #107 · Compounds › Tirzepatide · 23 Oct 2025 · 0 likes On post #106 — agreed on the reasoning, with one qualification. A methods point on SURMOUNT-4 rather than a substantive one: if the comparison is not like for like, the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #145 · Practice › Reconstitution · 15 Oct 2025 · 4 likes Before the thread moves on from 10 mg vial reconstituted three — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
-
Interim analyses and stopping rules Replied, post #2 · Evidence › Trials · 11 Oct 2025 · 18 likes Reframing interim analyses and stopping rules slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #131 · Practice › Side effects · 8 Oct 2025 · 28 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #41 · Compounds › Oral incretins · 22 Sep 2025 · 14 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #7 · Evidence › Study critique · 12 Sep 2025 · 2 likes On Reverse causation the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Why the timeline is on the right and not the left Replied, post #64 · Meta › Site feedback · 5 Sep 2025 · 0 likes Seconding that. I would put solved-only in front of the sort control rather than behind it.
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #34 · Practice › Dosing & titration · 31 Aug 2025 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #18 · Sourcing › Regulatory · 19 Aug 2025 · 11 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
A request that was declined, and the reasoning — a second dataset Replied, post #27 · Documentation › Wiki requests · 8 Aug 2025 · 0 likes Answering the question post #25 raises rather than the one it answers. Request a new maintained page: if a question recurs, has a good marked solution, and contains a…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #151 · Compounds › Tirzepatide · 30 Jul 2025 · 0 likes I had written a reply contradicting post #148 and deleted it. Here is what survived. The honest answer on tirzepatide in type 2 diabetes is that it depends, and the…
-
Counter-ion content and its effect on measured mass Replied, post #86 · Analytics › Mass spectrometry · 8 Jul 2025 · 11 likes On post #84 — agreed on the reasoning, with one qualification. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #80 · Wellbeing › Mental health · 30 Jun 2025 · 2 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #56 · Clinical › Comorbidities · 21 Jun 2025 · 0 likes For anyone finding this later: the short answer on Cardiovascular risk is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
A report I filed that turned out to be wrong, and the correction Replied, post #83 · Sourcing › Vendor reports · 2 Jun 2025 · 0 likes The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #73 · Practice › Reconstitution · 19 May 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I would treat…
-
Sequence verification for an obscure compound: how it is done Replied, post #37 · Compounds › Other compounds · 17 May 2025 · 2 likes Filing a mild objection to the consensus on sequence verification. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Why plausible mechanism is not evidence of effect Replied, post #7 · Compounds › Repair & healing peptides · 27 Apr 2025 · 0 likes This follows post #6 rather than contradicting it. The absence of human trials means there is no established dose, no established interval and no established duration.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #84 · Practice › Reconstitution · 20 Apr 2025 · 2 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #9 · Devices › Pens & autoinjectors · 13 Apr 2025 · 2 likes Storage instructions for a pen typically differ before and after first use, and the in-use period is the one people miss. It is on the carton. The number is defensible.…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #119 · Compounds › Semaglutide · 27 Mar 2025 · 17 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Coverage for the indication versus for the drug Replied, post #4 · Access › Insurance & coverage · 18 Mar 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Triple agonism: additive, synergistic, or neither? Replied, post #27 · Compounds › Retatrutide · 16 Mar 2025 · 15 likes I would rather this thread reach "we do not know" about triple agonism than reach a confident answer that nobody can support when asked.
-
Preparing for an appointment: one page, three questions Replied, post #11 · Clinical › Prescriber conversations · 16 Mar 2025 · 8 likes Answering the question post #9 raises rather than the one it answers. Take the actual numbers and the actual dates. A printed table beats a description and takes the…
-
A ten-fold dose error caught before injection Replied, post #7 · Devices › Syringes & needles · 8 Mar 2025 · 1 like Coming back to post #3, because the follow-up matters more than the original answer. The most useful thing anyone has posted about ten-fold dose error caught in this…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #48 · Documentation › Doc review · 7 Mar 2025 · 3 likes Careful with the language on draft on reconstitution arithmetic. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #97 · Sourcing › Regulatory · 3 Mar 2025 · 14 likes Adding a reference point for pharmaceutical compounding rules. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #72 · Sourcing › Regulatory · 2 Mar 2025 · 0 likes Where I part company with post #69, and it is a narrow parting. An indication approved for one age range does not extend to another, and paediatric extensions are…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #11 · Evidence › Meta-analyses · 26 Jan 2025 · 0 likes The claim about Random versus fixed effects upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #27 · Analytics › Mass spectrometry · 14 Jan 2025 · 5 likes Second-hand on mass spectrometry, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
What we do not know about retatrutide, listed explicitly Replied, post #52 · Compounds › Retatrutide · 11 Jan 2025 · 0 likes On post #50 — agreed on the reasoning, with one qualification. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #60 · Compounds › Semaglutide · 10 Dec 2024 · 13 likes The arithmetic in post #57 is right; the assumption feeding it is the part to check. The mass figure differs between sources because of how the different entities…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #40 · Practice › Reconstitution · 8 Dec 2024 · 22 likes This is the answer, and the reason it is the answer is the more useful part.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #56 · Compounds › Semaglutide · 2 Dec 2024 · 0 likes That is a cleaner way of putting what I was circling around.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #84 · Analytics › Method validation · 30 Nov 2024 · 0 likes The arithmetic in post #83 is right; the assumption feeding it is the part to check. A method that reports the same number for every lot is worth a second look. Real…
-
Requesting a page: what makes a good request — what changed since Replied, post #105 · Documentation › Wiki requests · 12 Oct 2024 · 0 likes On post #101 — agreed on the reasoning, with one qualification. Say what would make the page wrong. A page whose failure conditions are stated is much easier to review…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #87 · Access › Shortages · 12 Oct 2024 · 0 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect.
-
When to suspect the method rather than the sample Replied, post #20 · Analytics › Method validation · 6 Oct 2024 · 8 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. That…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #30 · Nutrition & Training › Resistance training · 11 Jul 2024 · 3 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. Cardiovascular work has its own benefits and is not a substitute for a resistance…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #2 · Evidence › Preprints · 20 May 2024 · 3 likes Coming back to the opening post, because the follow-up matters more than the original answer. Reading a preprint properly means doing some of the reviewer's job:…